日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial

口服索马鲁肽对高危 2 型糖尿病患者心血管危险因素的影响:SOUL 随机临床试验的事后二次分析

Mulvagh, Sharon L; Inzucchi, Silvio E; Marx, Nikolaus; Poulter, Neil R; Deanfield, John E; Pop-Busui, Rodica; Emerson, Scott S; Mann, Johannes F E; Engelmann, Mads D M; Hovingh, G Kees; Mandavya, Kabirdev; Davicevic-Elez, Zaklina; Jeppesen, Ole Kleist; Lorenzatti, Alberto; Oguz, Aytekin; Mankovsky, Boris; Deerochanawong, Chaicharn; Gorgojo-Martinez, Juan J; Ji, Linong; Bain, Stephen C; McGuire, Darren K; Buse, John B

Association Between the 2022 AHA/ACC/HFSA Heart Failure Staging and Cardiovascular and Kidney Outcomes in Patients With Diabetes and Kidney Disease: A Post Hoc Analysis of the SCORED Randomized Controlled Trial

2022 年 AHA/ACC/HFSA 心力衰竭分期与糖尿病合并肾病患者心血管和肾脏结局之间的关联:SCORED 随机对照试验的事后分析

Odutayo, Ayodele; Bhatt, Deepak L; Sridhar, Vikas S; Szarek, Michael; Cannon, Christopher P; Leiter, Lawrence A; McGuire, Darren K; Lewis, Julia B; Lopes, Renato D; Scirica, Benjamin M; Ray, Kausik K; Davies, Michael J; Banks, Phillip; Girard, Manon; Verma, Subodh; Udell, Jacob A; Pitt, Bertram; Steg, Ph Gabriel; Cherney, David Z I

Estimating the risk of cardiovascular outcomes and all-cause mortality in individuals with type 2 diabetes: Validation of the UKPDS outcomes model using TECOS and EXSCEL data

利用TECOS和EXSCEL数据验证UKPDS结局模型,评估2型糖尿病患者心血管事件和全因死亡风险

Coleman, Ruth L; Adler, Amanda I; Clarke, Philip M; McGuire, Darren K; Holman, Rury R

Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial

口服索马鲁肽对 2 型糖尿病患者心力衰竭结局的影响:SOUL 随机临床试验的二次分析

Pop-Busui, Rodica; Rasmussen, Søren; Deanfield, John E; Buse, John B; Marx, Nikolaus; Mulvagh, Sharon L; Inzucchi, Silvio E; Mann, Johannes F E; Emerson, Scott S; Poulter, Neil R; Engelmann, Mads D M; Hovingh, G Kees; Bayer Tanggaard, Katrine; Birkenfeld, Andreas L; Connelly, Kim A; Haluzik, Martin; Cavender, Matthew A; Kellerer, Monika; Jhund, Pardeep S; Gregersen, Søren; Nielsen, Olav Wendelboe; Lam, Carolyn S P; McGuire, Darren K

Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial

根据SGLT2i的使用情况,口服索马鲁肽对2型糖尿病患者心血管结局的影响:SOUL随机试验的预设分析

Marx, Nikolaus; Deanfield, John E; Mann, Johannes F E; Arechavaleta, Rosario; Bain, Stephen C; Bajaj, Harpreet S; Bayer Tanggaard, Katrine; Birkenfeld, Andreas L; Buse, John B; Davicevic-Elez, Zaklina; Desouza, Cyrus; Emerson, Scott S; Engelmann, Mads D M; Hovingh, G Kees; Inzucchi, Silvio E; Jhund, Pardeep S; Mulvagh, Sharon L; Pop-Busui, Rodica; Poulter, Neil R; Rasmussen, Søren; Tu, Shih-Te; McGuire, Darren K

Heart failure outcomes captured by adverse event reporting in participants with type 2 diabetes and atherosclerotic cardiovascular disease: Observations from the VERTIS CV trial

VERTIS CV试验中,通过不良事件报告记录的2型糖尿病合并动脉粥样硬化性心血管疾病患者的心力衰竭结局:

Pandey, Ambarish; Kolkailah, Ahmed A; McGuire, Darren K; Frederich, Robert C; Cater, Nilo B; Cosentino, Francesco; Pratley, Richard E; Dagogo-Jack, Samuel; Cherney, David Z I; Wynant, Willy; Gantz, Ira; Mancuso, James P; Masiukiewicz, Urszula; Cannon, Christopher P

Clinical perspectives of new insights and tools to minimize the hypoglycaemia burden connected with type 2 diabetes pharmacotherapy

从临床角度探讨减少2型糖尿病药物治疗相关低血糖负担的新见解和工具

Standl, Eberhard; Ceriello, Antonio; McGuire, Darren K; Schnell, Oliver; Holman, Rury R

Cardiometabolic risk factors and disease trends for atrial fibrillation in individuals with type 1 diabetes: a nationwide registry study

型糖尿病患者房颤的心血管代谢危险因素和疾病趋势:一项全国性登记研究

El Khalili, Lara; El Khalili, Linn; Rawshani, Araz; Borén, Jan; Bhatt, Deepak L; Gerstein, Hertzel C; McGuire, Darren K; Helleryd, Edvin; Omerovic, Elmir; Eliasson, Björn; Råmunddal, Truuls; Sattar, Naveed; Rawshani, Aidin

Treatment strategies to reduce cardiovascular risk in persons with chronic kidney disease and Type 2 diabetes

降低慢性肾病合并2型糖尿病患者心血管风险的治疗策略

Zannad, Faiez; McGuire, Darren K; Ortiz, Alberto

Characteristics of patients prescribed SGLT-2i and/or GLP-1RA among cardiology clinics in the US: insights from the COORDINATE-diabetes trial

美国心脏病诊所中接受SGLT-2抑制剂和/或GLP-1受体激动剂治疗的患者特征:来自COORDINATE-diabetes试验的启示

Nelson, Adam J; Kaltenbach, Lisa A; Al-Khalidi, Hussein R; Leyva, Monica; Webb, Laura; McGuire, Darren K; Pop-Busui, Rodica; Cavender, Matthew A; Aroda, Vanita R; Magwire, Melissa L; Richardson, Caroline R; Lingvay, Ildiko; Kirk, Julienne K; Pandey, Ambarish; Gaynor, Tanya; Pak, Jonathan; Washington, Alana; Senyucel, Cagri; Lopes, Renato D; Green, Jennifer B; Granger, Christopher B; Pagidipati, Neha J